These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 21938449

  • 1. Expression of the cholera toxin B subunit (CT-B) in maize seeds and a combined mucosal treatment against cholera and traveler's diarrhea.
    Karaman S, Cunnick J, Wang K.
    Plant Cell Rep; 2012 Mar; 31(3):527-37. PubMed ID: 21938449
    [Abstract] [Full Text] [Related]

  • 2. A functional antigen in a practical crop: LT-B producing maize protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT).
    Chikwamba R, Cunnick J, Hathaway D, McMurray J, Mason H, Wang K.
    Transgenic Res; 2002 Oct; 11(5):479-93. PubMed ID: 12437079
    [Abstract] [Full Text] [Related]

  • 3. Analysis of immune response in young and aged mice vaccinated with corn-derived antigen against Escherichia coli heat-labile enterotoxin.
    Karaman S, Cunnick J, Wang K.
    Mol Biotechnol; 2006 Jan; 32(1):31-42. PubMed ID: 16382180
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae.
    Ryan ET, Crean TI, John M, Butterton JR, Clements JD, Calderwood SB.
    Infect Immun; 1999 Apr; 67(4):1694-701. PubMed ID: 10085006
    [Abstract] [Full Text] [Related]

  • 9. Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine.
    Tokuhara D, Yuki Y, Nochi T, Kodama T, Mejima M, Kurokawa S, Takahashi Y, Nanno M, Nakanishi U, Takaiwa F, Honda T, Kiyono H.
    Proc Natl Acad Sci U S A; 2010 May 11; 107(19):8794-9. PubMed ID: 20421480
    [Abstract] [Full Text] [Related]

  • 10. Immunization against Vibrio cholerae, ETEC, and EHEC with chitosan nanoparticle containing LSC chimeric protein.
    Ghaffari Marandi BH, Zolfaghari MR, Kazemi R, Motamedi MJ, Amani J.
    Microb Pathog; 2019 Sep 11; 134():103600. PubMed ID: 31202906
    [Abstract] [Full Text] [Related]

  • 11. Expression and immunogenicity of enterotoxigenic Escherichia coli heat-labile toxin B subunit in transgenic rice callus.
    Kim TG, Kim BG, Kim MY, Choi JK, Jung ES, Yang MS.
    Mol Biotechnol; 2010 Jan 11; 44(1):14-21. PubMed ID: 19657748
    [Abstract] [Full Text] [Related]

  • 12. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
    Holmgren J, Bourgeois L, Carlin N, Clements J, Gustafsson B, Lundgren A, Nygren E, Tobias J, Walker R, Svennerholm AM.
    Vaccine; 2013 May 07; 31(20):2457-64. PubMed ID: 23541621
    [Abstract] [Full Text] [Related]

  • 13. Mucosal and systemic antibody responses after peroral or intranasal immunization: effects of conjugation to enterotoxin B subunits and/or of co-administration with free toxin as adjuvant.
    Rask C, Fredriksson M, Lindblad M, Czerkinsky C, Holmgren J.
    APMIS; 2000 Mar 07; 108(3):178-86. PubMed ID: 10752686
    [Abstract] [Full Text] [Related]

  • 14. Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein.
    Lundgren A, Leach S, Tobias J, Carlin N, Gustafsson B, Jertborn M, Bourgeois L, Walker R, Holmgren J, Svennerholm AM.
    Vaccine; 2013 Feb 06; 31(8):1163-70. PubMed ID: 23306362
    [Abstract] [Full Text] [Related]

  • 15. Low-dose exposure and immunogenicity of transgenic maize expressing the Escherichia coli heat-labile toxin B subunit.
    Beyer AJ, Wang K, Umble AN, Wolt JD, Cunnick JE.
    Environ Health Perspect; 2007 Mar 06; 115(3):354-60. PubMed ID: 17431483
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A tripartite fusion, FaeG-FedF-LT(192)A2:B, of enterotoxigenic Escherichia coli (ETEC) elicits antibodies that neutralize cholera toxin, inhibit adherence of K88 (F4) and F18 fimbriae, and protect pigs against K88ac/heat-labile toxin infection.
    Ruan X, Liu M, Casey TA, Zhang W.
    Clin Vaccine Immunol; 2011 Oct 06; 18(10):1593-9. PubMed ID: 21813665
    [Abstract] [Full Text] [Related]

  • 19. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
    Holmgren J, Czerkinsky C, Lycke N, Svennerholm AM.
    Am J Trop Med Hyg; 1994 Oct 06; 50(5 Suppl):42-54. PubMed ID: 8203723
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.